Lara Roberts/LinkedIn
Oct 16, 2025, 06:13
Lara Roberts Published “Anticoagulation in Cirrhosis: The New Standard”
Nazim Arain, Consultant Internal Medicine & Gastroenterologist at Almana Group of Hospitals, shared a post on LinkedIn:
“Anticoagulation in Cirrhosis: The New Standard
Patients with cirrhosis face an increased risk of thrombotic events like AF and VTE.
It’s now accepted that their coagulation is “rebalanced,” making anticoagulation the standard of care to reduce stroke/thrombosis risk!
The primary bleeding risk is linked to portal hypertension, NOT general clotting deficiency.
Direct Oral Anticoagulants (DOACs) can be considered for Child-Pugh A & B patients.
LMWH often preferred in Child-Pug-C.”
Title: Anticoagulation in cirrhosis
Authors: Lara Roberts
Read the full review here.
Stay updated with Hemostasis Today.
-
Jun 22, 2026, 05:59Harshdeep Singh: Why Platelet Counts Matter Less Than the Cause
-
Jun 22, 2026, 05:45Shakti Bedanta Mishra: A Practical Guide to Hematology in Critical Care
-
Jun 22, 2026, 05:29Tara Munn: The Human Experience of Immune Thrombocytopenia At Sanofi
-
Jun 22, 2026, 04:06Gaurav Gupta: Unlocking the Inflammatory Mechanisms of Hemorrhagic Stroke Recovery
-
Jun 22, 2026, 03:47Flora Peyvandi: Optimizing Plasma Transfusion in Cirrhosis
-
Jun 21, 2026, 23:55Arun V. J.: At ISBT, the Best Innovations Are Often Already Among Us
-
Jun 21, 2026, 23:38David Armstrong: Healing Ulcers Fast with Low Thrombosis Risk with Total-Contact Casts
-
Jun 21, 2026, 20:12Large Meta-Analysis Highlights Key Predictors of Major Bleeding With DOAC Therapy – JTH
-
Jun 21, 2026, 19:19Tribikram Panda: Ensuring Global Equity in Management of Sickle Cell Disease